EGFR is not a major driver for osteosarcoma cell growth in vitro but contributes to starvation and chemotherapy resistance
Florian Sevelda(Medical University of Vienna), Walter Berger(Comprehensive Cancer Center Vienna)
Cited by 75
Related Papers
Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis
|Oncotarget|2013|57
Distinct activity of the bone-targeted gallium compound KP46 against osteosarcoma cells - synergism with autophagy inhibition
|Journal of Experimental & Clinical Cancer Research|2017|38
The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation
|Pharmaceutics|2022|37